arrow
M

Michał Biśta

captor therapeutics inc
H指数:21
被引数:3,553

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cover Feature: Ligand-Induced Conformational Plasticity of the CTLH E3 Ligase Receptor GID4 (ChemMedChem 7/2026)

封面报道:配体诱导的CTLH E3连接酶受体GID4构象可塑性(ChemMedChem 7/2026)

2026-04-180
OAAI
Ligand-Induced Conformational Plasticity of the CTLH E3 Ligase Receptor GID4

配体诱导的CTLH E3连接酶受体GID4的构象可塑性

2026-04-030
PRE
Discovery of 6-Fluoro-5-{4-[(5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD9574): A CNS-Penetrant, PARP1-Selective Inhibitor
2024-12-100
PRE
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs
2021-09-2781
PREAI
Potent and Selective Inhibitors of the Epidermal Growth Factor Receptor to Overcome C797S-Mediated Resistance
2021-09-0721
PRE
A head-to-head comparison of the properties of five clinical PARP inhibitors identifies new insights that can explain both the observed clinical efficacy and safety profiles
2018-07-0120
PRE
Structural and functional characterization of SplA, an exclusively specific protease of Staphylococcus aureus

金黄色葡萄球菌特异性蛋白酶SplA的结构和功能表征

2009-04-1432
OAAI